For example, in influenza A virus, vaccine strains that elicit higher T lymphocyte responses correlate with enhanced viral clearance and reduced clinical disease [38, 39], while in vaccinia virus, strains that stimulate robust CD4+ lymphocyte responses provide improved protection upon virulence infection [33]. This evidence concerns the gene CD4 and infection.